Loading…

Clinical strategy study on prenatal screening and diagnostic model for Down syndrome

Exploring efficient and easily implementable prenatal screening strategies aims at birth defect prevention and control. However, there have been limited economic evaluations of non-invasive prenatal screening (NIPS) strategies in China. Furthermore, these studies were predominantly confined to local...

Full description

Saved in:
Bibliographic Details
Published in:Scientific reports 2024-09, Vol.14 (1), p.22269-11, Article 22269
Main Authors: Luo, Wei, Liu, Sha, He, Bin, Han, Daiwen, Yuan, Lixing, Zhao, Kai, Tang, Jun, Pang, Ling, Zou, Fene, Liu, Jianlong, Liu, Hongqian, Bai, Ting, Jing, Xiaosha, Xia, Tianyu, Deng, Cechuan, Liu, Yunyun, Cheng, Jing, Wei, Xiang, Xing, Lingling, Luo, Yuan, Zhou, Quanfang, Zhu, Qian, Liu, Shanling
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c422t-fe33015456a57610063b2d9f052b500c2e86ee5a7456d24d1a9ff177af09879b3
container_end_page 11
container_issue 1
container_start_page 22269
container_title Scientific reports
container_volume 14
creator Luo, Wei
Liu, Sha
He, Bin
Han, Daiwen
Yuan, Lixing
Zhao, Kai
Tang, Jun
Pang, Ling
Zou, Fene
Liu, Jianlong
Liu, Hongqian
Bai, Ting
Jing, Xiaosha
Xia, Tianyu
Deng, Cechuan
Liu, Yunyun
Cheng, Jing
Wei, Xiang
Xing, Lingling
Luo, Yuan
Zhou, Quanfang
Zhu, Qian
Liu, Shanling
description Exploring efficient and easily implementable prenatal screening strategies aims at birth defect prevention and control. However, there have been limited economic evaluations of non-invasive prenatal screening (NIPS) strategies in China. Furthermore, these studies were predominantly confined to local or geographically proximate provinces and lacked universality and representativeness. This study assesses the health economics of current prenatal screening strategies and NIPS as first-line screening programs, analyzing their efficacy to determine an optimal strategy. From the perspective of health economics, cost-effectiveness, cost-benefit, and single-factor sensitivity were conducted for five different screening strategies using a decision tree model. Among pregnant women aged 
doi_str_mv 10.1038/s41598-024-73183-4
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_e34de58b872d4efb86493e4d7bc95457</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_e34de58b872d4efb86493e4d7bc95457</doaj_id><sourcerecordid>3110578482</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-fe33015456a57610063b2d9f052b500c2e86ee5a7456d24d1a9ff177af09879b3</originalsourceid><addsrcrecordid>eNp9Uk1v1DAQtRAVrbb9AxyQJS5cAv6M7RNCy1elSr2Us-XEk5BVYi92QrX_HndTSsuhvnjkefP8ZuYh9JqS95Rw_SELKo2uCBOV4lTzSrxAZ4wIWTHO2MtH8Sm6yHlHypHMCGpeoVNuOOeMkzN0sx2HMLRuxHlObob-UILFH3AMeJ8guPku1SaAMIQeu-CxH1wfYp6HFk_Rw4i7mPDneBtwPgSf4gTn6KRzY4aL-3uDfnz9crP9Xl1df7vcfrqqWsHYXHXAOaFSyNpJVVNCat4wb7qis5GEtAx0DSCdKgjPhKfOdB1VynXEaGUavkGXK6-Pbmf3aZhcOtjoBnt8iKm3LhWdI1jgwoPUjVbMC-gaXQvDQXjVtKYoUIXr48q1X5oJfAuhzGN8Qvo0E4afto-_LaWCK1KbwvDuniHFXwvk2U5DbmEcXYC4ZMspJapsoLS5QW__g-7ikkKZ1REllRaaFRRbUW2KOSfoHtRQYu9MYFcT2GICezSBFaXozeM-Hkr-rrwA-ArIJRV6SP_-fob2DzNwvEI</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3110578482</pqid></control><display><type>article</type><title>Clinical strategy study on prenatal screening and diagnostic model for Down syndrome</title><source>Publicly Available Content Database</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><source>Springer Nature - nature.com Journals - Fully Open Access</source><creator>Luo, Wei ; Liu, Sha ; He, Bin ; Han, Daiwen ; Yuan, Lixing ; Zhao, Kai ; Tang, Jun ; Pang, Ling ; Zou, Fene ; Liu, Jianlong ; Liu, Hongqian ; Bai, Ting ; Jing, Xiaosha ; Xia, Tianyu ; Deng, Cechuan ; Liu, Yunyun ; Cheng, Jing ; Wei, Xiang ; Xing, Lingling ; Luo, Yuan ; Zhou, Quanfang ; Zhu, Qian ; Liu, Shanling</creator><creatorcontrib>Luo, Wei ; Liu, Sha ; He, Bin ; Han, Daiwen ; Yuan, Lixing ; Zhao, Kai ; Tang, Jun ; Pang, Ling ; Zou, Fene ; Liu, Jianlong ; Liu, Hongqian ; Bai, Ting ; Jing, Xiaosha ; Xia, Tianyu ; Deng, Cechuan ; Liu, Yunyun ; Cheng, Jing ; Wei, Xiang ; Xing, Lingling ; Luo, Yuan ; Zhou, Quanfang ; Zhu, Qian ; Liu, Shanling</creatorcontrib><description>Exploring efficient and easily implementable prenatal screening strategies aims at birth defect prevention and control. However, there have been limited economic evaluations of non-invasive prenatal screening (NIPS) strategies in China. Furthermore, these studies were predominantly confined to local or geographically proximate provinces and lacked universality and representativeness. This study assesses the health economics of current prenatal screening strategies and NIPS as first-line screening programs, analyzing their efficacy to determine an optimal strategy. From the perspective of health economics, cost-effectiveness, cost-benefit, and single-factor sensitivity were conducted for five different screening strategies using a decision tree model. Among pregnant women aged &lt; 35 years who underwent only one screening for foetal Down syndrome (DS), the detection rate, false positive rate and positive predictive value of NIPS for foetuses with DS were superior to those of the other four serological screening methods. Although applying NIPS as first-line screening method yields the highest efficacy and benefits, it currently lacks cost-effectiveness when compared to serological screening and sequential NIPS screening strategies.</description><identifier>ISSN: 2045-2322</identifier><identifier>EISSN: 2045-2322</identifier><identifier>DOI: 10.1038/s41598-024-73183-4</identifier><identifier>PMID: 39333230</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/308/2056 ; 692/53/2423 ; 692/700/3934 ; Adult ; Birth defects ; China - epidemiology ; Congenital defects ; Cost analysis ; Cost-Benefit Analysis ; Down syndrome ; Down Syndrome - diagnosis ; Down's syndrome ; Economics ; Female ; Health economics ; Humanities and Social Sciences ; Humans ; multidisciplinary ; Non-invasive prenatal screening ; Noninvasive Prenatal Testing - methods ; Pregnancy ; Prenatal diagnosis ; Prenatal Diagnosis - economics ; Prenatal Diagnosis - methods ; Science ; Science (multidisciplinary) ; Serological screening ; Serology</subject><ispartof>Scientific reports, 2024-09, Vol.14 (1), p.22269-11, Article 22269</ispartof><rights>The Author(s) 2024</rights><rights>2024. The Author(s).</rights><rights>The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2024 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c422t-fe33015456a57610063b2d9f052b500c2e86ee5a7456d24d1a9ff177af09879b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/3110578482/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3110578482?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39333230$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Luo, Wei</creatorcontrib><creatorcontrib>Liu, Sha</creatorcontrib><creatorcontrib>He, Bin</creatorcontrib><creatorcontrib>Han, Daiwen</creatorcontrib><creatorcontrib>Yuan, Lixing</creatorcontrib><creatorcontrib>Zhao, Kai</creatorcontrib><creatorcontrib>Tang, Jun</creatorcontrib><creatorcontrib>Pang, Ling</creatorcontrib><creatorcontrib>Zou, Fene</creatorcontrib><creatorcontrib>Liu, Jianlong</creatorcontrib><creatorcontrib>Liu, Hongqian</creatorcontrib><creatorcontrib>Bai, Ting</creatorcontrib><creatorcontrib>Jing, Xiaosha</creatorcontrib><creatorcontrib>Xia, Tianyu</creatorcontrib><creatorcontrib>Deng, Cechuan</creatorcontrib><creatorcontrib>Liu, Yunyun</creatorcontrib><creatorcontrib>Cheng, Jing</creatorcontrib><creatorcontrib>Wei, Xiang</creatorcontrib><creatorcontrib>Xing, Lingling</creatorcontrib><creatorcontrib>Luo, Yuan</creatorcontrib><creatorcontrib>Zhou, Quanfang</creatorcontrib><creatorcontrib>Zhu, Qian</creatorcontrib><creatorcontrib>Liu, Shanling</creatorcontrib><title>Clinical strategy study on prenatal screening and diagnostic model for Down syndrome</title><title>Scientific reports</title><addtitle>Sci Rep</addtitle><addtitle>Sci Rep</addtitle><description>Exploring efficient and easily implementable prenatal screening strategies aims at birth defect prevention and control. However, there have been limited economic evaluations of non-invasive prenatal screening (NIPS) strategies in China. Furthermore, these studies were predominantly confined to local or geographically proximate provinces and lacked universality and representativeness. This study assesses the health economics of current prenatal screening strategies and NIPS as first-line screening programs, analyzing their efficacy to determine an optimal strategy. From the perspective of health economics, cost-effectiveness, cost-benefit, and single-factor sensitivity were conducted for five different screening strategies using a decision tree model. Among pregnant women aged &lt; 35 years who underwent only one screening for foetal Down syndrome (DS), the detection rate, false positive rate and positive predictive value of NIPS for foetuses with DS were superior to those of the other four serological screening methods. Although applying NIPS as first-line screening method yields the highest efficacy and benefits, it currently lacks cost-effectiveness when compared to serological screening and sequential NIPS screening strategies.</description><subject>692/308/2056</subject><subject>692/53/2423</subject><subject>692/700/3934</subject><subject>Adult</subject><subject>Birth defects</subject><subject>China - epidemiology</subject><subject>Congenital defects</subject><subject>Cost analysis</subject><subject>Cost-Benefit Analysis</subject><subject>Down syndrome</subject><subject>Down Syndrome - diagnosis</subject><subject>Down's syndrome</subject><subject>Economics</subject><subject>Female</subject><subject>Health economics</subject><subject>Humanities and Social Sciences</subject><subject>Humans</subject><subject>multidisciplinary</subject><subject>Non-invasive prenatal screening</subject><subject>Noninvasive Prenatal Testing - methods</subject><subject>Pregnancy</subject><subject>Prenatal diagnosis</subject><subject>Prenatal Diagnosis - economics</subject><subject>Prenatal Diagnosis - methods</subject><subject>Science</subject><subject>Science (multidisciplinary)</subject><subject>Serological screening</subject><subject>Serology</subject><issn>2045-2322</issn><issn>2045-2322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9Uk1v1DAQtRAVrbb9AxyQJS5cAv6M7RNCy1elSr2Us-XEk5BVYi92QrX_HndTSsuhvnjkefP8ZuYh9JqS95Rw_SELKo2uCBOV4lTzSrxAZ4wIWTHO2MtH8Sm6yHlHypHMCGpeoVNuOOeMkzN0sx2HMLRuxHlObob-UILFH3AMeJ8guPku1SaAMIQeu-CxH1wfYp6HFk_Rw4i7mPDneBtwPgSf4gTn6KRzY4aL-3uDfnz9crP9Xl1df7vcfrqqWsHYXHXAOaFSyNpJVVNCat4wb7qis5GEtAx0DSCdKgjPhKfOdB1VynXEaGUavkGXK6-Pbmf3aZhcOtjoBnt8iKm3LhWdI1jgwoPUjVbMC-gaXQvDQXjVtKYoUIXr48q1X5oJfAuhzGN8Qvo0E4afto-_LaWCK1KbwvDuniHFXwvk2U5DbmEcXYC4ZMspJapsoLS5QW__g-7ikkKZ1REllRaaFRRbUW2KOSfoHtRQYu9MYFcT2GICezSBFaXozeM-Hkr-rrwA-ArIJRV6SP_-fob2DzNwvEI</recordid><startdate>20240927</startdate><enddate>20240927</enddate><creator>Luo, Wei</creator><creator>Liu, Sha</creator><creator>He, Bin</creator><creator>Han, Daiwen</creator><creator>Yuan, Lixing</creator><creator>Zhao, Kai</creator><creator>Tang, Jun</creator><creator>Pang, Ling</creator><creator>Zou, Fene</creator><creator>Liu, Jianlong</creator><creator>Liu, Hongqian</creator><creator>Bai, Ting</creator><creator>Jing, Xiaosha</creator><creator>Xia, Tianyu</creator><creator>Deng, Cechuan</creator><creator>Liu, Yunyun</creator><creator>Cheng, Jing</creator><creator>Wei, Xiang</creator><creator>Xing, Lingling</creator><creator>Luo, Yuan</creator><creator>Zhou, Quanfang</creator><creator>Zhu, Qian</creator><creator>Liu, Shanling</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><general>Nature Portfolio</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20240927</creationdate><title>Clinical strategy study on prenatal screening and diagnostic model for Down syndrome</title><author>Luo, Wei ; Liu, Sha ; He, Bin ; Han, Daiwen ; Yuan, Lixing ; Zhao, Kai ; Tang, Jun ; Pang, Ling ; Zou, Fene ; Liu, Jianlong ; Liu, Hongqian ; Bai, Ting ; Jing, Xiaosha ; Xia, Tianyu ; Deng, Cechuan ; Liu, Yunyun ; Cheng, Jing ; Wei, Xiang ; Xing, Lingling ; Luo, Yuan ; Zhou, Quanfang ; Zhu, Qian ; Liu, Shanling</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-fe33015456a57610063b2d9f052b500c2e86ee5a7456d24d1a9ff177af09879b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>692/308/2056</topic><topic>692/53/2423</topic><topic>692/700/3934</topic><topic>Adult</topic><topic>Birth defects</topic><topic>China - epidemiology</topic><topic>Congenital defects</topic><topic>Cost analysis</topic><topic>Cost-Benefit Analysis</topic><topic>Down syndrome</topic><topic>Down Syndrome - diagnosis</topic><topic>Down's syndrome</topic><topic>Economics</topic><topic>Female</topic><topic>Health economics</topic><topic>Humanities and Social Sciences</topic><topic>Humans</topic><topic>multidisciplinary</topic><topic>Non-invasive prenatal screening</topic><topic>Noninvasive Prenatal Testing - methods</topic><topic>Pregnancy</topic><topic>Prenatal diagnosis</topic><topic>Prenatal Diagnosis - economics</topic><topic>Prenatal Diagnosis - methods</topic><topic>Science</topic><topic>Science (multidisciplinary)</topic><topic>Serological screening</topic><topic>Serology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Luo, Wei</creatorcontrib><creatorcontrib>Liu, Sha</creatorcontrib><creatorcontrib>He, Bin</creatorcontrib><creatorcontrib>Han, Daiwen</creatorcontrib><creatorcontrib>Yuan, Lixing</creatorcontrib><creatorcontrib>Zhao, Kai</creatorcontrib><creatorcontrib>Tang, Jun</creatorcontrib><creatorcontrib>Pang, Ling</creatorcontrib><creatorcontrib>Zou, Fene</creatorcontrib><creatorcontrib>Liu, Jianlong</creatorcontrib><creatorcontrib>Liu, Hongqian</creatorcontrib><creatorcontrib>Bai, Ting</creatorcontrib><creatorcontrib>Jing, Xiaosha</creatorcontrib><creatorcontrib>Xia, Tianyu</creatorcontrib><creatorcontrib>Deng, Cechuan</creatorcontrib><creatorcontrib>Liu, Yunyun</creatorcontrib><creatorcontrib>Cheng, Jing</creatorcontrib><creatorcontrib>Wei, Xiang</creatorcontrib><creatorcontrib>Xing, Lingling</creatorcontrib><creatorcontrib>Luo, Yuan</creatorcontrib><creatorcontrib>Zhou, Quanfang</creatorcontrib><creatorcontrib>Zhu, Qian</creatorcontrib><creatorcontrib>Liu, Shanling</creatorcontrib><collection>Springer_OA刊</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>Proquest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Science Journals</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Scientific reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Luo, Wei</au><au>Liu, Sha</au><au>He, Bin</au><au>Han, Daiwen</au><au>Yuan, Lixing</au><au>Zhao, Kai</au><au>Tang, Jun</au><au>Pang, Ling</au><au>Zou, Fene</au><au>Liu, Jianlong</au><au>Liu, Hongqian</au><au>Bai, Ting</au><au>Jing, Xiaosha</au><au>Xia, Tianyu</au><au>Deng, Cechuan</au><au>Liu, Yunyun</au><au>Cheng, Jing</au><au>Wei, Xiang</au><au>Xing, Lingling</au><au>Luo, Yuan</au><au>Zhou, Quanfang</au><au>Zhu, Qian</au><au>Liu, Shanling</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical strategy study on prenatal screening and diagnostic model for Down syndrome</atitle><jtitle>Scientific reports</jtitle><stitle>Sci Rep</stitle><addtitle>Sci Rep</addtitle><date>2024-09-27</date><risdate>2024</risdate><volume>14</volume><issue>1</issue><spage>22269</spage><epage>11</epage><pages>22269-11</pages><artnum>22269</artnum><issn>2045-2322</issn><eissn>2045-2322</eissn><abstract>Exploring efficient and easily implementable prenatal screening strategies aims at birth defect prevention and control. However, there have been limited economic evaluations of non-invasive prenatal screening (NIPS) strategies in China. Furthermore, these studies were predominantly confined to local or geographically proximate provinces and lacked universality and representativeness. This study assesses the health economics of current prenatal screening strategies and NIPS as first-line screening programs, analyzing their efficacy to determine an optimal strategy. From the perspective of health economics, cost-effectiveness, cost-benefit, and single-factor sensitivity were conducted for five different screening strategies using a decision tree model. Among pregnant women aged &lt; 35 years who underwent only one screening for foetal Down syndrome (DS), the detection rate, false positive rate and positive predictive value of NIPS for foetuses with DS were superior to those of the other four serological screening methods. Although applying NIPS as first-line screening method yields the highest efficacy and benefits, it currently lacks cost-effectiveness when compared to serological screening and sequential NIPS screening strategies.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>39333230</pmid><doi>10.1038/s41598-024-73183-4</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2045-2322
ispartof Scientific reports, 2024-09, Vol.14 (1), p.22269-11, Article 22269
issn 2045-2322
2045-2322
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_e34de58b872d4efb86493e4d7bc95457
source Publicly Available Content Database; PubMed Central; Free Full-Text Journals in Chemistry; Springer Nature - nature.com Journals - Fully Open Access
subjects 692/308/2056
692/53/2423
692/700/3934
Adult
Birth defects
China - epidemiology
Congenital defects
Cost analysis
Cost-Benefit Analysis
Down syndrome
Down Syndrome - diagnosis
Down's syndrome
Economics
Female
Health economics
Humanities and Social Sciences
Humans
multidisciplinary
Non-invasive prenatal screening
Noninvasive Prenatal Testing - methods
Pregnancy
Prenatal diagnosis
Prenatal Diagnosis - economics
Prenatal Diagnosis - methods
Science
Science (multidisciplinary)
Serological screening
Serology
title Clinical strategy study on prenatal screening and diagnostic model for Down syndrome
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T07%3A17%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20strategy%20study%20on%20prenatal%20screening%20and%20diagnostic%20model%20for%20Down%20syndrome&rft.jtitle=Scientific%20reports&rft.au=Luo,%20Wei&rft.date=2024-09-27&rft.volume=14&rft.issue=1&rft.spage=22269&rft.epage=11&rft.pages=22269-11&rft.artnum=22269&rft.issn=2045-2322&rft.eissn=2045-2322&rft_id=info:doi/10.1038/s41598-024-73183-4&rft_dat=%3Cproquest_doaj_%3E3110578482%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c422t-fe33015456a57610063b2d9f052b500c2e86ee5a7456d24d1a9ff177af09879b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3110578482&rft_id=info:pmid/39333230&rfr_iscdi=true